Cargando…

Chromatin as a target antigen in human and murine lupus nephritis

The present review focuses on pathogenic molecular and transcriptional events in patients with lupus nephritis. These factors are renal DNaseI, exposed chromatin fragments and the corresponding chromatin-reactive autoantibodies. Lupus nephritis is the most serious complication in human systemic lupu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hedberg, Annica, Mortensen, Elin S, Rekvig, Ole P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132027/ https://www.ncbi.nlm.nih.gov/pubmed/21542875 http://dx.doi.org/10.1186/ar3281

Ejemplares similares

Anti-dsDNA Antibodies Promote Initiation, and Acquired Loss of Renal Dnase1 Promotes Progression of Lupus Nephritis in Autoimmune (NZBxNZW)F1 Mice
por: Fenton, Kristin, et al.
Publicado: (2009)

Silencing of Renal DNaseI in Murine Lupus Nephritis Imposes Exposure of Large Chromatin Fragments and Activation of Toll Like Receptors and the Clec4e
por: Thiyagarajan, Dhivya, et al.
Publicado: (2012)

Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis
por: Tveita, Anders, et al.
Publicado: (2008)

Renal Dnase1 Enzyme Activity and Protein Expression Is Selectively Shut Down in Murine and Human Membranoproliferative Lupus Nephritis
por: Zykova, Svetlana N., et al.
Publicado: (2010)

Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis
por: Becker-Merok, Andrea, et al.
Publicado: (2006)

The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be
por: Rekvig, Ole Petter
Publicado: (2019)

LMW Heparin Prevents Increased Kidney Expression of Proinflammatory Mediators in (NZBxNZW)F1 Mice
por: Hedberg, Annica, et al.
Publicado: (2013)

The role of aldosterone blockade in murine lupus nephritis
por: Monrad, Seetha U, et al.
Publicado: (2008)

Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas
por: Rekvig, Ole Petter
Publicado: (2018)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Heterogeneity and clonality of kidney-infiltrating T cells in murine lupus nephritis
por: Smita, Shuchi, et al.
Publicado: (2022)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

The Role of Autophagy in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2015)

Podocyte Injury in Lupus Nephritis
por: Sakhi, Hamza, et al.
Publicado: (2019)

Individualizing Therapy in Lupus Nephritis
por: An, Yu, et al.
Publicado: (2019)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Inhibition of Sphingosine Kinase-2 in a Murine Model of Lupus Nephritis
por: Snider, Ashley J., et al.
Publicado: (2013)

The Role of Cytokine in the Lupus Nephritis
por: Iwata, Yasunori, et al.
Publicado: (2011)

Current status of lupus nephritis
por: Jaryal, Ajay, et al.
Publicado: (2017)

Urinary biomarkers in lupus nephritis
por: Aragón, Cristian C., et al.
Publicado: (2020)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus and Lupus Nephritis: Potential Therapeutic Target
por: Li, Hui-Yuan, et al.
Publicado: (2023)

Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus
Publicado: (1996)

Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
por: Reddy, Padmalatha S, et al.
Publicado: (2008)

Lupus nephritis progression in FcγRIIB(-/-)yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease
por: Horvei, Kjersti Daae, et al.
Publicado: (2017)

Mechanisms of tissue injury in lupus nephritis
por: Nowling, Tamara K, et al.
Publicado: (2011)

Toll-like receptors in lupus nephritis
por: Devarapu, Satish Kumar, et al.
Publicado: (2018)

Kidney outcomes for children with lupus nephritis
por: Oni, Louise, et al.
Publicado: (2020)

Lupus Nephritis in Children: Novel Perspectives
por: Pennesi, Marco, et al.
Publicado: (2023)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
por: Schwartzman-Morris, Julie, et al.
Publicado: (2012)

Identification and characterization of antigen-specific CD4(+) T cells targeting renally expressed antigens in human lupus nephritis with two independent methods
por: Tesch, Sebastian, et al.
Publicado: (2020)

Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?
por: Parodis, Ioannis, et al.
Publicado: (2022)

Targeting Regulatory T Cells for Therapy of Lupus Nephritis
por: Venkatadri, Rajkumar, et al.
Publicado: (2022)

Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal?
por: Nossent, Hans C, et al.
Publicado: (2005)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)

Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression
por: Pedersen, Hege L, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3gg31q94e58am1qctkseihncgr